Press releases
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People
- Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time
More ▼
Key statistics
On Friday, Dexcom Inc (DC4:STU) closed at 122.64, -6.71% below its 52-week high of 131.46, set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 124.64 |
---|---|
High | 124.64 |
Low | 121.60 |
Bid | 122.58 |
Offer | 122.82 |
Previous close | 126.06 |
Average volume | 26.60 |
---|---|
Shares outstanding | 385.52m |
Free float | 383.97m |
P/E (TTM) | 101.96 |
Market cap | 50.39bn USD |
EPS (TTM) | 1.28 USD |
Data delayed at least 15 minutes, as of Apr 19 2024.
More ▼